Efferon Unveils Blood‑Purification Device Targeting Pediatric Sepsis

Battlefield 200‑backed startup Efferon has introduced a blood‑purification technology designed to combat pediatric sepsis, a condition that claims thousands of young lives each year. The device aims to filter harmful pathogens from a child's bloodstream, offering a potential lifesaving intervention.

According to the company, the system can be integrated into existing hospital equipment and is intended for use in intensive care settings. Efferon hopes the technology will reduce the high mortality rate associated with severe infections in children.

The startup plans to pursue regulatory approvals and clinical trials to validate the device’s efficacy and safety before broader deployment.

Why It Matters

Pediatric sepsis remains a leading cause of child mortality in the US and Europe, making new treatment options critical for healthcare systems.